On this page you will find any clinical guidance and treatment pathways that have been approved by GMMMG or its Subgroups.
Documents are listed alphabetically.
The ‘Document Title’, ‘Issue Date’ and ‘Review Date’ headings below are active links. Click a heading to sort in ascending or descending order.
|Document Title||Issue Date||Review Date||Status|
|Engagement with the Pharmaceutical Industry||20171226 Dec 2017||20201226 Dec 2020|
|GMMMG Appeals Policy||20171226 Dec 2017||20201226 Dec 2020|
|GMMMG Declaration of interests - form||20160926 Sep 2016||20190926 Sep 2019|
|GMMMG Declaration of interests - policy||20160926 Sep 2016||20190926 Sep 2019|
|Guidelines for defining Red, Amber, Green, DNP and Grey status||20210826 Aug 2021|
|High cost drug business case template||20131026 Oct 2013|
|High cost drugs service development guideline||20131026 Oct 2013|
|Management of Red Listed drugs in primary care||20190426 Apr 2019||20220426 Apr 2022|
|Primary care rebate schemes|